Osteoradionecrosis of the mandible: Minimized risk profile following intensity-modulated radiation therapy (IMRT)

Strahlentherapie und Onkologie

Volumn 182, Issue 5, 2006, Pages 283-288

  Studer, Gabriela ^a   Studer, Stephan Philipp ^a   Zwahlen, Roger Arthur ^a   Huguenin, Pia ^a   Grätz, Klaus Wilhelm ^a   Lütolf, Urs Martin ^a   Glanzmann, Christoph ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Dental implants; IMRT; Mandible bone; Normal tissue tolerance; Osteoradionecrosis

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; BONE NECROSIS; BONE REGENERATION; CANCER CHEMOTHERAPY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER SYSTEM; DESCRIPTIVE RESEARCH; DOSE VOLUME HISTOGRAM; FEMALE; FOLLOW UP; HISTOGRAM; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MANDIBLE; MOUTH TUMOR; OROPHARYNX TUMOR; POSTOPERATIVE CARE; RADIATION DOSE; RADIATION EXPOSURE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TOOTH IMPLANTATION; TREATMENT PLANNING; VOLUMETRY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; DENTAL IMPLANTS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MANDIBLE; MANDIBULAR DISEASES; MIDDLE AGED; OSTEORADIONECROSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RISK FACTORS; TIME FACTORS;

EID: 33646574947     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-1477-0     Document Type: Article

References (23)

1. Balogh JM, Sutherland SE. Osteoradionecrosis of the mandible: a review. J Otolaryngol 1989;18:245-50.
2. Bras J, de Jonge HK, van Merkesteyn JP. Osteoradionecrosis of the mandible: pathogenesis. Am J Otolaryngol 1990;11:244-50.
3. Daly T. Dental care in the irradiated patient. In: Fletcher GH, eds. Textbook of radiotherapy. Philadelphia: Lea & Febiger, 1980:229-36.
4. De Arruda FF, et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2006;64:363-73.
5. Emami B, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-22.
6. Esser E, Wagner W. Dental implants following radical oral cancer surgery and adjuvant radiotherapy. Int J Oral Maxillofac Implants 1997;12:552-7.
7. Glanzmann C, Gratz KW. Radionecrosis of the mandibula: a retrospective analysis of the incidence and risk factors. Radiother Oncol 1995;36:94-100.
8. Granstrom G. Osseointegration in irradiated cancer patients: an analysis with respect to implant failures. J Oral Maxillofac Surg 2005;63:579-85.
9. Gregoire V, et al. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 2000;56:135-50.
10. Grosu AL, et al. Positron emission tomography for radiation treatment planning. Strahlenther Onkol 2005;181:481-99.
11. Grotz KA, et al. [Prognosis and prognostic factors of endosseous implants in the irradiated jaw.] Mund Kiefer Gesichtschir 1999;3:Suppl 1:117-24.
12. Haas R, et al. Survival of 1,920 IMZ implants followed for up to 100 months. Int J Oral Maxillofac Implants 1996;11:581-8.
13. Jereczek-Fossa BA, et al. Analysis of mandibular dose distribution in radiotherapy for oropharyngeal cancer: dosimetric and clinical results in 18 patients. Radiother Oncol 2003;66:49-56.
14. Kuhnt T, et al. Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer. Strahlenther Onkol 2005;181:520-8.
15. Kutta H, et al. Amifostine is a potent radioprotector of salivary glands in radioiodine therapy. Strahlenther Onkol 2005;181:237-45.
16. Momm F, et al. Different saliva substitutes for treatment of xerostomia following radiotherapy. Strahlenther Onkol 2005;181:231-6.
17. Noack N, Willer J, Hoffmann J. Long-term results after placement of dental implants: longitudinal study of 1,964 implants over 16 years. Int J Oral Maxillofac Implants 1999;14:748-55.
18. Parliament M, et al. Implications of radiation dosimetry of the mandible in patients with carcinomas of the oral cavity and nasopharynx treated with intensity modulated radiation therapy. Int J Oral Maxillofac Surg 2005;34:114-21.
19. Studer G, Gratz KW, Glanzmann C. Osteoradionecrosis of the mandibula in patients treated with different fractionations. Strahlenther Onkol 2004;180:233-40.
20. Takacsi-Nagy Z, et al. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma. Strahlenther Onkol 2003;180:768-75.
21. Visch LL, et al. A clinical evaluation of implants in irradiated oral cancer patients. J Dent Res 2002;81:856-9.
22. Weischer T, Mohr C. Ten-year experience in oral implant rehabilitation of cancer patients: treatment concept and proposed criteria for success. Int J Oral Maxillofac Implants 1999;14:521-8.
23. Wiltfang J, et al. Beurteilung der Lebensqualität von Patienten mit Plattenepithelkarzinomen der Mundhöhle. Strahlenther Onkol 2003;179:682-9.